Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVIATOR: ABT-450/r, Ombitasvir, and Dasabuvir in HCV Genotype 1
NCT01464827Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2011
- Primary completion
- Mar 2013
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 2 trial of paritaprevir, ombitasvir, dasabuvir in hepatitis C (HCV), sponsored by AbbVie Inc.. Started Oct 2011; status: completed.
02
Drugs
paritaprevirombitasvirdasabuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01464827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01464827.